Electra Q2 2026 profit lifted by non-cash fair value gains, company says

Reuters2026/08/12 11:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Electra posted net income of CAD 9.03 million for Q2 2026, driven mainly by non-cash fair-value adjustments.
US Warrant fair-value gain totaled CAD 15.23 million, offset partly by CAD 2.18 million in other non-operating expense tied to FX moves.
Operating expenses rose to CAD 4.02 million from CAD 3.48 million, reflecting higher professional fees and share-based compensation.
Current liabilities fell to CAD 44.48 million from CAD 88.17 million at Dec. 31, 2025, largely due to US warrant revaluation.
Refinery execution remained the core focus, with a US$ 73 million construction budget targeting commissioning in Q4 2026, commercial production in Q4 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electra Battery Materials Corporation published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23